Helix BioMedix, Inc. (HXBM)
USD 12.0
(20.0%)
USD 12.0
(20.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.04 Million USD | 8.61% |
| 2022 | -1.17 Million USD | 0.0% |
| 2011 | -2.29 Million USD | 19.25% |
| 2010 | -2.84 Million USD | 7.93% |
| 2009 | -3.08 Million USD | 9.47% |
| 2008 | -3.41 Million USD | -1.98% |
| 2007 | -3.34 Million USD | 10.12% |
| 2006 | -3.72 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - USD | 8.61% |
| 2022 FY | - USD | 0.0% |
| 2011 FY | - USD | 19.25% |
| 2010 FY | - USD | 7.93% |
| 2009 FY | - USD | 9.47% |
| 2008 FY | - USD | -1.98% |
| 2007 FY | - USD | 10.12% |
| 2006 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 98.527% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 82.352% |
| SQZ Biotechnologies Company | -64.14 Million USD | 98.369% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 93.976% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 101.113% |
| Mesoblast Limited | -62.38 Million USD | 98.323% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 31.883% |
| Genus plc | 73.7 Million USD | 101.42% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 84.174% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 70.501% |
| Marizyme, Inc. | -34.28 Million USD | 96.948% |
| ContraFect Corporation | -64.99 Million USD | 98.39% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 88.072% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 76.883% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 25.36% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 60.434% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 54.974% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -101.973% |
| Accustem Sciences Inc. | -3.74 Million USD | 72.072% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 97.83% |
| EV Biologics, Inc. | -1.26 Million USD | 17.427% |
| Q BioMed Inc. | -617.62 Thousand USD | -69.408% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 129.292% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -65.449% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 54.199% |
| Biomind Labs Inc. | -1.03 Million USD | -1.137% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 110.593% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 85.389% |
| Skye Bioscience, Inc. | -13.54 Million USD | 92.277% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 29.656% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -4085.248% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 73.063% |
| IMV Inc. | -35.52 Million USD | 97.055% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 93.407% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 58.18% |
| GB Sciences, Inc. | -1.41 Million USD | 26.31% |
| Alpha Cognition Inc. | -9.7 Million USD | 89.22% |
| HST Global, Inc. | -5303.00 USD | -19630.568% |
| CSL Limited | 4.78 Billion USD | 100.022% |
| Halberd Corporation | -74.27 Thousand USD | -1308.624% |
| Enzolytics Inc. | -2.12 Million USD | 50.693% |
| Resverlogix Corp. | -11.74 Million USD | 91.089% |
| Affymax, Inc. | -14.29 Million USD | 92.681% |
| SYBLEU INC | -141.57 Thousand USD | -639.072% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 65.84% |
| argenx SE | -216.02 Million USD | 99.516% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 98.109% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 185.975% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 30.195% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 376.185% |
| AVAX Technologies, Inc. | -6.11 Million USD | 82.883% |
| Zenith Capital Corp. | -8.6 Million USD | 87.842% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.579% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -5906.039% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 57.232% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -494.413% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 97.36% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 63.825% |
| Adynxx, Inc. | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 15660.857% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 40.211% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 45.53% |
| BioStem Technologies, Inc. | -7.55 Million USD | 86.148% |
| ONE Bio Corp. | 13.61 Million USD | 107.686% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -477.792% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 49.134% |
| Agentix Corp. | -1.37 Million USD | 23.725% |
| LadRx Corporation | 412.28 Thousand USD | 353.785% |
| Cell Source, Inc. | -4.27 Million USD | 75.511% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -184.927% |
| Regen BioPharma, Inc. | 1.46 Million USD | 171.374% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -11.672% |
| NovAccess Global Inc. | -1.03 Million USD | -1.113% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 111.818% |
| Itoco Inc. | -1.86 Million USD | 44.017% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -175.621% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 6.244% |
| Kadimastem Ltd | -2.62 Million USD | 60.131% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -337.513% |
| CytoDyn Inc. | -18.02 Million USD | 94.197% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -1223.96% |
| Mobile Lads Corp. | -2.24 Million USD | 53.314% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -8455.99% |
| Qrons Inc. | -40.08 Thousand USD | -2510.494% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -115.433% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 298.378% |
| Rebus Holdings, Inc. | -951 Thousand USD | -10.022% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 1.478% |
| International Stem Cell Corporation | 202 Thousand USD | 617.976% |
| Bioxytran, Inc. | -3.82 Million USD | 72.611% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1887.675% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 57.5% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 97.083% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -2225.138% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 61.786% |
| Neutra Corp. | -181.24 Thousand USD | -477.285% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 94.81% |
| PureTech Health plc | -11.62 Million USD | 91.001% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 94.809% |
| IXICO plc | -707 Thousand USD | -47.993% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 86.385% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 97.836% |
| CSL Limited | 4.73 Billion USD | 100.022% |
| Cellectis S.A. | -92.63 Million USD | 98.871% |